SCHEMBL2083374

SCHEMBL2083374

c1ccc2c(c1)CCC2c1cccc2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G6 O60733 4/20 0.49
MAPK1 P28482 2/20 0.49
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
FAAH O00519 1/20 0.49
NPC1 O15118 1/20 0.49
GMNN O75496 1/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
MTOR P42345 1/20 0.49
RAB9A P51151 1/20 0.49
BLM P54132 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TRPC5 Q9UL62 1/20 0.49
TRPC6 Q9Y210 1/20 0.49
TP53 P04637 1/20 0.49
CYP3A4 P08684 1/20 0.49
PKM P14618 1/20 0.49
ALOX15 P16050 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29625707 0.89 ALDH1A1 (0.49) PLA2G6MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL11676259 0.89 ALDH1A1 (0.49) PLA2G6MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL18554493 0.85 CYP1A2 (0.43) PLA2G6MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL10685434 0.81 IDO1 (0.53) PLA2G6MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL15874768 0.80 CYP19A1 (0.52) PLA2G6MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL15874769 0.80 CYP19A1 (0.52) PLA2G6MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL8640805 0.76 CYP1A2 (0.50) ALDH1A1HPGDSMN1; SMN2CYP1A2CYP2D6
SCHEMBL11442085 0.76 ALDH1A1 (0.44) MAPK1ALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL6140008 0.75 ALDH1A1 (0.41) PLA2G6MAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL29853558 0.75 GID4 (0.52) MAPK1ALDH1A1HPGDSMN1; SMN2BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113967-A1 ENZYME MODULATORS AND TREATMENTS DECIPHERA PHARMACEUTICALS, LLC (US) 2008-05-15 US claimed
EP-1835934-A2 ENZYME MODULATORS AND TREATMENTS Deciphera Pharmaceuticals, LLC (US) 2007-09-26 EP claimed
US-20070078121-A1 Enzyme modulators and treatments DECIPHERA PHARMACEUTICALS, LLC 2007-04-05 US claimed
WO-2006071940-A2 ENZYME MODULATORS AND TREATMENTS DECIPHERA PHARMACEUTICALS, LLC (US) 2006-07-06 WO claimed
CN-110072842-A Molecules having pesticidal utility, and intermediates, compositions and methods related thereto 美国陶氏益农公司 2019-07-30 CN disclosed
CN-107105657-A Molecule and relative intermediate, composition and method with desinsection effectiveness 美国陶氏益农公司 2017-08-29 CN disclosed
US-8846019-B2 Use of protoberberines as an active substance regulating the pilosebaceous unit SEDERMA (FR) 2014-09-30 US disclosed
US-8591874-B2 Inhibition of mammalian hair growth THE PROCTER & GAMBLE COMPANY (US) 2013-11-26 US disclosed
US-8481015-B2 Applying agmatine and a dermatologically acceptable carrier to the skin; inhibiting hair growth THE PROCTER & GAMBLE COMPANY (US) 2013-07-09 US disclosed
US-8163756-B2 For example,1-(3-t-butyl-1- (1,2,3,4-tetrahydro- isoquinolin-6-yl)-1H- pyrazol-5-yl)-3-(3- cyanophenyl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies DECIPHERA PHARMACEUTICALS, LLC (US) 2012-04-24 US disclosed
CN-1756527-B Regulation of mammalian hair growth PROCTER & GAMBLE 2010-12-08 CN disclosed
US-20090269395-A1 USE OF PROTOBERBERINES AS AN ACTIVE SUBSTANCE REGULATING THE PILOSEBACEOUS UNIT SEDERMA (FR) 2009-10-29 US disclosed
EP-1601340-A2 REGULATION OF MAMMALIAN HAIR GROWTH THE PROCTER & GAMBLE COMPANY (US) 2005-12-07 EP disclosed
WO-2005110353-A1 PERSONAL CARE COMPOSITIONS AND METHODS FOR REGULATING MAMMALIAN HAIR GROWTH AND SKIN CONDITION THE PROCTER & GAMBLE COMPANY (US) 2005-11-24 WO disclosed
WO-2005110352-A1 PERSONAL CARE COMPOSITIONS AND METHODS REGULATING MAMMALIAN GROWTH THE PROCTER & GAMBLE COMPANY (US) 2005-11-24 WO disclosed
US-20050255059-A1 Personal care compositions and methods regulating mammalian hair growth PROCTER & GAMBLE COMPANY, THE 2005-11-17 US disclosed
US-20050255060-A1 Personal care compositions and methods regulating mammalian hair growth PROCTER & GAMBLE COMPANY, THE 2005-11-17 US disclosed
US-20050245615-A1 Composition containing polyamine transport inhibitor and use thereof MEDIQUEST THERAPEUTICS, INC. (US) 2005-11-03 US disclosed
US-20050003024-A1 Regulation of mammalian hair growth THE PROCTER & GAMBLE COMPANY 2005-01-06 US disclosed
WO-2004078157-A2 REGULATION OF MAMMALIAN HAIR GROWTH THE PROCTER & GAMBLE COMPANY (US) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050255059-A1 Personal care compositions and methods regulating mammalian hair growth PLOD3, MITF, AADAT PLA2G6 2811/4885MAPK1 1418/4885ALDH1A1 3562/4885
US-20090269395-A1 USE OF PROTOBERBERINES AS AN ACTIVE SUBSTANCE REGULATING THE PILOSEBACEOUS UNIT BROX, CUTA, SHH PLA2G6 1217/4885MAPK1 3401/4885ALDH1A1 3956/4885
US-20050245615-A1 Composition containing polyamine transport inhibitor and use thereof SLC7A1, SRM, SLC16A1 PLA2G6 2718/4885MAPK1 2388/4885ALDH1A1 1242/4885
US-20070078121-A1 Enzyme modulators and treatments ABL1, ABL2, LCK PLA2G6 2078/4885MAPK1 72/4885ALDH1A1 1036/4885
US-20050255060-A1 Personal care compositions and methods regulating mammalian hair growth PCMT1, PLOD3, ARNT PLA2G6 3219/4885MAPK1 2186/4885ALDH1A1 3085/4885
US-20050003024-A1 Regulation of mammalian hair growth BHMT, UGCG, HNMT PLA2G6 1909/4885MAPK1 636/4885ALDH1A1 3099/4885
US-20080113967-A1 ENZYME MODULATORS AND TREATMENTS ABL2, BRAF, MAP3K1 PLA2G6 2370/4885MAPK1 43/4885ALDH1A1 1274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.